GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » Current Accrued Expense

Notable Labs (Notable Labs) Current Accrued Expense : $0.11 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Notable Labs Current Accrued Expense?

Notable Labs's Current Accrued Expense for the quarter that ended in Dec. 2023 was $0.11 Mil.

Notable Labs's quarterly Current Accrued Expense declined from Dec. 2021 ($0.89 Mil) to Dec. 2022 ($0.65 Mil) and declined from Dec. 2022 ($0.65 Mil) to Dec. 2023 ($0.11 Mil).

Notable Labs's annual Current Accrued Expense declined from Dec. 2021 ($0.89 Mil) to Dec. 2022 ($0.65 Mil) and declined from Dec. 2022 ($0.65 Mil) to Dec. 2023 ($0.11 Mil).

Notable Labs Current Accrued Expense Historical Data

The historical data trend for Notable Labs's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Notable Labs Current Accrued Expense Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
Current Accrued Expense
0.89 0.65 0.11

Notable Labs Semi-Annual Data
Dec21 Dec22 Dec23
Current Accrued Expense 0.89 0.65 0.11

Notable Labs Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Notable Labs Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Notable Labs's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Notable Labs (Notable Labs) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » Current Accrued Expense
Comparable Companies
NLSP ACST AGE CRBP NBIO CLRB AIM PLUR BIXT SNSE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
320 Hatch Drive, Foster City, CA, USA, 94404
Website
https://notablelabs.com
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic.